首页 > 市场调查报告书 > 医疗设备

颅内动脉瘤市场规模、份额和成长分析（按产品类型、类型、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1898588

颅内动脉瘤市场规模、份额和成长分析（按产品类型、类型、最终用户和地区划分）—2026-2033年产业预测

Intracranial Aneurysm Market Size, Share, and Growth Analysis, By Product Type (Aneurysm Therapeutic Devices, Embolization Devices), By Type (Saccular aneurysm, Fusiform aneurysm), By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球颅内动脉瘤市场规模预计在 2024 年达到 14.2 亿美元，从 2025 年的 15.5 亿美元增长到 2033 年的 30.8 亿美元，在预测期（2026-2033 年）内复合年增长率为 9%。

受人口老化、早期诊断和介入意识增强以及医疗技术快速发展的推动，全球颅内动脉瘤市场持续稳定成长。已开发市场和新兴市场医疗费用支出的增加，提高了患者获得必要诊断和治疗服务的可近性。微创血管内治疗技术的创新，例如栓塞术和血流晶粒，因其创伤小、住院时间短、康復快而备受青睐。此外，先进的影像技术提高了检测精度和治疗方案製定的准确性。然而，高昂的治疗费用和复杂手术带来的风险等挑战，可能会阻碍患者和医疗机构对这些技术的接受度。因此，降低治疗成本并提高治疗的安全性和有效性，对于市场发展至关重要。

全球颅内动脉瘤市场驱动因素

全球颅内动脉瘤市场的成长主要得益于医疗技术的进步。微创血管内治疗、先进的影像技术以及尖端医疗设备的研发等创新倡议，都有助于改善治疗效果。这些技术进步不仅提升了治疗效果，也减轻了患者的负担，缩短了復原时间。随着医疗专业人员不断采用这些先进治疗方法，市场呈现上升趋势，这反映了在改善脑动脉瘤患者照护和优化治疗方案方面所做的持续努力。

限制全球颅内动脉瘤市场的因素

全球颅内动脉瘤市场面临严峻挑战，治疗费用高昂，尤其是需要特殊医疗设备和外科手术的复杂病例。不断上涨的费用会限制患者获得必要的治疗，特别是经济条件有限的患者。此外，医疗系统面临的经济负担会阻碍整体服务提供，并导致治疗机会不均等。这种经济障碍凸显了开发创新解决方案的必要性，这些方案旨在提高成本效益，并使颅内动脉瘤患者更容易获得有效治疗。

全球颅内动脉瘤市场趋势

全球颅内动脉瘤市场正迅速向微创手术转型，尤其是血管内介入技术，例如栓塞术和血流晶粒术。这一趋势反映了整个医疗领域以患者为中心的更广泛趋势，强调减少创伤和加快康復速度。随着这些技术的日益精进，它们相比传统开放性手术具有显着优势，包括创伤更小、患者预后更佳。先进影像和导管技术的应用进一步加速了这一趋势，促进了这些手术的广泛普及。这种不断变化的格局表明，神经外科领域对兼顾疗效和患者舒适度的创新治疗方法的需求日益增长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic plc（Ireland）
Stryker Corporation（United States）
MicroPort Scientific Corporation（China）
Johnson & Johnson Services, Inc.（United States）
MicroVention Inc.（United States）
B. Braun Melsungen AG（Germany）
Integra LifeSciences（United States）
RAUMEDIC AG（Germany）
Terumo Corporation（Japan）
Delta Surgical（United Kingdom）
MicroVention Terumo（United States）
Penumbra, Inc.（United States）
Balt USA（United States）
Phenox GmbH（Germany）
InspireMD, Inc.（Israel）
Kaneka Medix Corporation（Japan）
Evasc Neurovascular Enterprises ULC（Canada）

结论与建议

简介目录

Product Code: SQMIG35A2427

Global Intracranial Aneurysm Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.55 Billion in 2025 to USD 3.08 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The global market for intracranial aneurysms is witnessing consistent expansion, fueled by an aging demographic, heightened awareness regarding early diagnosis and intervention, and rapid advancements in medical technology. Increased healthcare spending in both developed and emerging markets is enhancing accessibility to essential diagnostic and therapeutic services. Innovations in minimally invasive endovascular techniques, such as coiling and flow diversion, are particularly favored for their reduced invasiveness, shorter hospital stays, and quicker recovery. Additionally, advanced imaging technologies have improved detection accuracy and treatment planning. However, challenges such as the high costs of treatment and the risks associated with complex procedures may hinder patient and provider adoption. Focusing on cost reduction and refining treatment safety and efficacy will be crucial for market progression.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intracranial Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intracranial Aneurysm Market Segments Analysis

Global Intracranial Aneurysm Market is segmented by Product Type, Type, End-User and region. Based on Product Type, the market is segmented into Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices and Access Devices. Based on Type, the market is segmented into Saccular aneurysm, Fusiform aneurysm and Mycotic aneurysm. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intracranial Aneurysm Market

The growth of the global intracranial aneurysm market is significantly propelled by advancements in medical technology. Innovations such as minimally invasive endovascular procedures, enhanced imaging techniques, and the creation of cutting-edge devices contribute to improvements in treatment efficacy. These technological breakthroughs not only result in superior patient outcomes but also minimize discomfort and lead to quicker recovery periods. As healthcare practitioners continue to adopt these advanced modalities, the market is poised for expansion, reflecting the ongoing commitment to improving patient care and optimizing therapeutic approaches for managing intracranial aneurysms.

Restraints in the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market faces significant challenges due to the high costs associated with treatment, particularly for complex cases that necessitate specialized medical devices or surgical procedures. These elevated expenses can restrict patient access to essential care, particularly among those with limited financial resources. Additionally, the financial burden imposed on healthcare systems can hinder the overall provision of services, potentially resulting in inequalities in treatment availability. This economic barrier underscores the need for innovative solutions that can improve affordability and facilitate broader access to effective interventions for patients suffering from intracranial aneurysms.

Market Trends of the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market is increasingly shifting towards minimally invasive procedures, particularly endovascular techniques like coiling and flow diversion. This trend reflects a broader healthcare emphasis on patient-centered care, emphasizing reduced invasiveness and shorter recovery periods. As these techniques become more refined, they offer significant advantages over traditional open surgeries, including decreased trauma and enhanced patient outcomes. The adoption of advanced imaging and catheter-based technologies further propels this movement, making such procedures more prevalent. This evolving landscape signals a rising demand for innovative treatment options that prioritize both efficacy and patient comfort within the neurosurgery sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Intracranial Aneurysm Market Size by Product Type & CAGR (2026-2033)

Market Overview
Aneurysm Therapeutic Devices
- Clips
- Coils
- Intravascular Devices
- Flow Diverter
Embolization Devices
- Occlusion Catheters
- Embolic Agent
Aspiration Devices
- Aspiration Catheter
- Clot Retrieval Device
Access Devices
- Micro Catheter
- Guidewire

Global Intracranial Aneurysm Market Size by Type & CAGR (2026-2033)

Market Overview
Saccular aneurysm
Fusiform aneurysm
Mycotic aneurysm

Global Intracranial Aneurysm Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Intracranial Aneurysm Market Size & CAGR (2026-2033)

North America (Product Type, Type, End-User)
- US
- Canada
Europe (Product Type, Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAUMEDIC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delta Surgical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Terumo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Medix Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evasc Neurovascular Enterprises ULC (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments